Klein, Florian

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

Gruell, H., Vanshylla, K., Tober-Lau, P., Hillus, D., Schommers, P., Lehmann, C., Kurth, F., Sander, L. E., & Klein, F. (2022) · Nature Medicine

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 410

Regulation of the multidrug resistance transporter P‐glycoprotein in multicellular tumor spheroids by hypoxia‐inducible factor‐1 and reactive oxygen species

Wartenberg, M., Ling, F. C., Müschen, M., Klein, F., Acker, H., Gassmann, M., Petrat, K., Pütz, V., Hescheler, J., & Sauer, H. (2003) · The FASEB Journal

Drug Transport and Resistance MechanismsCancer, Hypoxia, and Metabolism

Cited by 287

In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation

Jensen, B.-E. O., Knops, E., Cords, L., Lübke, N., Salgado, M., Busman-Sahay, K., Estes, J. D., Huyveneers, L. E. P., Perdomo-Celis, F., Wittner, M., et al. (2023) · Nature Medicine

HIV Research and TreatmentVirus-based gene therapy research

Cited by 158

Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans

Vanshylla, K., Di Cristanziano, V., Kleipass, F., Dewald, F., Schommers, P., Gieselmann, L., Gruell, H., Schlotz, M., Ercanoglu, M. S., Stumpf, R., et al. (2021) · Cell Host & Microbe

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 153

Relationship between intact HIV-1 proviruses in circulating CD4 + T cells and rebound viruses emerging during treatment interruption

Lu, C.-L., Pai, J. A., Nogueira, L., Mendoza, P., Gruell, H., Oliveira, T. Y., Barton, J., Lorenzi, J. C. C., Cohen, Y. Z., Cohn, L. B., et al. (2018) · Proceedings of the National Academy of Sciences

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 77

Long-term immunogenicity of BNT162b2 vaccination in the elderly and in younger health care workers

Tober-Lau, P., Schwarz, T., Vanshylla, K., Hillus, D., Gruell, H., EICOV/COVIM Study Group, Suttorp, N., Landgraf, I., Kappert, K., Seybold, J., et al. (2021) · The Lancet Respiratory Medicine

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

Cited by 69

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

Kreer, C., Zehner, M., Weber, T., Ercanoglu, M. S., Gieselmann, L., Rohde, C., Halwe, S., Korenkov, M., Schommers, P., Vanshylla, K., et al. (2020) · Cell

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 67

Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation

Gaebler, C., Kor, S., Allers, K., Perotti, M., Mwangi, D., Meixenberger, K., Hanke, K., Trenkner, T., Kraus, T., Sha, Y., et al. (2026) · Nature

HIV Research and TreatmentVirus-based gene therapy research

Cited by 16

Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

Otte, F., Zhang, Y., Spagnuolo, J., Thielen, A., Däumer, M., Wiethe, C., Stoeckle, M., Kusejko, K., Klein, F., Metzner, K. J., et al. (2023) · Cell Reports Methods

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 4